(Q34522360)

2 August 2017

The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma (English)

1 reference

2 August 2017

1 reference

P M Bhende

1

1 reference

2 August 2017

S I Park

2

1 reference

2 August 2017

M S Lim

3

1 reference

2 August 2017

D P Dittmer

4

1 reference

2 August 2017

B Damania

5

1 reference

2 August 2017

12 August 2010

1 reference

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

1781-1784

1 reference

2 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.154

2 August 2017

0 references

cites work

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

AKT/PKB signaling: navigating downstream

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Syk-dependent mTOR activation in follicular lymphoma cells.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2010.154

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2010.154

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027218

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib*

27 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2010.154

p53 mutation is associated with progression in follicular lymphomas

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20703254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p53 mutations are associated with histologic transformation of follicular lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20703254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.154

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference